- Home
- CLDX vs CET Comparison
CLDX vs CET Comparison
Compare CLDX & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDX | CET |
|---|---|---|
| Founded | N/A | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLDX | CET |
|---|---|---|
| Price | $27.52 | $50.49 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $43.80 | N/A |
| AVG Volume (30 Days) | ★ 775.5K | 48.9K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.40 |
| Revenue | $2,599,000.00 | ★ $27,062,484.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.70 | N/A |
| P/E Ratio | ★ N/A | $6.84 |
| Revenue Growth | N/A | ★ 15.78 |
| 52 Week Low | $14.40 | $40.24 |
| 52 Week High | $30.50 | $52.44 |
Technical Indicators
Market Signals| Indicator | CLDX | CET |
|---|---|---|
| Relative Strength Index (RSI) | 52.62 | 53.64 |
| Support Level | $27.51 | $49.91 |
| Resistance Level | $28.79 | $50.95 |
| Average True Range (ATR) | 1.34 | 0.69 |
| MACD | 0.04 | 0.16 |
| Stochastic Oscillator | 43.25 | 80.20 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.